Troluce Capital Advisors »

Bridgebio Pharma shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.4M 100k 74.48

More positions owned by Troluce Capital Advisors

Ishares Tr Russell 2000 Etf Put Option (IWM)
Space Exploration Techn Corp Class A Com Stk Put Option (SPCX)
Echostar Corp Cl A Call Option
Amentum Holdings (AMTM)
Globalstar Com New Call Option (GSAT)
Mineralys Therapeutics (MLYS)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Mirion Technologies Com Cl A (MIR)
Advanced Energy Industries (AEIS)
Stoke Therapeutics (STOK)
Timken Company Call Option (TKR)
Amazon Call Option (AMZN)
General Dynamics Corporation (GD)
Nrg Energy Com New Call Option (NRG)
Bridgebio Pharma Call Option (BBIO)

View all positions for Troluce Capital Advisors

Top funds holding Bridgebio Pharma

Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Wellington Management Company
State Street Corporation
Two Sigma Investments
Aisling Capital Management
Citadel Advisors

View all funds holding Bridgebio Pharma